Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Scientific Reports|November 7, 2014
Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injuryShutaro Ishimura, Masato Furuhashi, Tomohiro Mita, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 13, 2015
Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertensionMasato Furuhashi, Tomohiro Mita, Norihito Moniwa, et al.
Case Reports in Nephrology and Dialysis|March 30, 2018
A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated VasculitisMarenao Tanaka, Norihito Moniwa, Tomohiro Mita, et al.
American Journal of Hypertension|June 22, 2012
Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevationHideki Ota, Masato Furuhashi, Shutaro Ishimura, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|January 26, 2022
Impact of catheter contact angle on lesion formation and durability of pulmonary vein isolationMasayuki Ohta, Kentaro Hayashi, Hiroyuki Sato, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 28, 2021
Impact of Frailty on Bleeding Events Related to Anticoagulation Therapy in Patients With Atrial FibrillationMasayuki Ohta, Kentaro Hayashi, Yuichiro Mori, et al.
Lipids in Health and Disease|January 13, 2016
Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl estersMasato Furuhashi, Shinya Hiramitsu, Tomohiro Mita, et al.
Plos One|December 16, 2014
Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunctionYusuke Okazaki, Masato Furuhashi, Marenao Tanaka, et al.
Plos One|November 27, 2013
Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general populationShutaro Ishimura, Masato Furuhashi, Yuki Watanabe, et al.
Journal of Lipid Research|October 16, 2015
Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitusMasato Furuhashi, Shinya Hiramitsu, Tomohiro Mita, et al.
Pageof 3